Form 4: ICU Medical Inc. Executive Sells Shares in Recent Transaction
SEC Form 4 Filing
Daniel Woolson, VP and GM of Infusion Capital at ICU Medical Inc., sold 2,241 shares of common stock on December 6, 2024.
Summary
- Daniel Woolson, a VP and GM at ICU Medical Inc., sold 2,241 shares of common stock on December 6, 2024.
- The shares were sold at a price of $156.251 per share.
- Following the transaction, Mr. Woolson directly owns 10,866 shares of ICU Medical Inc. stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of an executive stock sale, which is a common occurrence and does not indicate any positive or negative sentiment.
Industry Context
This is a routine Form 4 filing, which is common for executives who trade company stock. It does not indicate any specific trend in the medical device industry.
Comparison to Industry Standards
- Executive stock sales are a normal part of compensation and portfolio management in publicly traded companies.
- The sale by Daniel Woolson is similar to other executive transactions in the medical device industry, such as those seen at Medtronic or Boston Scientific.
Stakeholder Impact
- The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date of the stock sale transaction by Daniel Woolson. |
Keywords
ICU Medical Inc, stock sale, insider trading, executive transaction, Daniel Woolson, ICUI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.